Suggestions
Simon Westbrook
CEO at Levicept Ltd
Professional Background
Simon Westbrook is a renowned entrepreneur and innovative scientist specializing in drug discovery and development, with an impressive career spanning over 20 years in the biotechnology industry. His dedication to creating first-class innovative therapies is evident through his extensive experience and successful track record. He has managed numerous teams throughout the various stages of drug discovery, driving teams towards achieving significant milestones that include delivering numerous candidate compounds to Phase I trials and achieving three positive Phase II proof of concept (PoC) results.
Education and Achievements
Dr. Westbrook completed his academic training at La Trobe University, where he earned a PhD in Physiology and a Bachelor of Agricultural Science (BAgrSci). His solid academic foundation laid the groundwork for a thriving career in biotechnology. Among his notable accomplishments is the founding of three biotech companies, which reflects his entrepreneurial spirit and commitment to innovation in the life sciences field.
Innovations and Contributions
Westbrook is known for his prominent contributions to the biotechnology landscape, particularly as an inventor of LEVICEPT, a groundbreaking therapy aimed at addressing specific health concerns. In addition, he played a pivotal role as a co-inventor in the development of a treatment for Overactive Bladder, leading the project from the idea stage through to Phase II proof of concept. Furthermore, he achieved proof of concept in Stress Urinary Incontinence and spearheaded both Phase II and Phase III studies for a diabetes and obesity treatment. These achievements demonstrate his ability to translate scientific ideas into effective therapies that have the potential to improve patients’ lives.
In recognition of his contributions to the industry, Simon was awarded the prestigious Pfizer Achievement Award for Serial Innovation in 2010. This accolade underscores his relentless pursuit of innovative solutions within the pharmaceutical domain. His expertise in innovation and drug discovery is sought after, making him a valuable leader in any biotechnology venture.
Leadership Roles
Throughout his career, Simon has held various influential positions within leading organizations. Currently, he serves as the CEO and Founder of Levicept Ltd, where he continues to push the boundaries of innovative therapies. His previous roles include being the Founder of Inhibitaxin Ltd and serving as an Associate Research Fellow at Pfizer, in addition to holding several key research positions, such as Senior Principal Scientist and Senior Scientist at Pfizer. He also gained valuable early career experience as a Post Doctoral Scientist at the Babraham Institute and Austin Hospital in Melbourne. These experiences have equipped him with broad insights and expertise that he applies in his current endeavors.
In summary, Simon Westbrook’s career journey reflects his unwavering commitment to the field of biotechnology. With a focus on delivering pioneering therapies and a robust background in drug discovery, he continues to be a driving force in the industry. Through his innovative approaches and leadership capabilities, Simon exemplifies the ideal combination of scientific rigor and entrepreneurial spirit that is essential for advancing healthcare solutions.
